Sex Differences in Intensity of Care and Outcomes After Acute Ischemic Stroke Across the Age Continuum.

Neurology

From the Department of Medicine (Neurology) (A.Y.X.Y.), University of Toronto, Sunnybrook Health Sciences Centre, Ontario, Canada; ICES (A.Y.X.Y., P.C.A., M.R., J.F., J.P., M.V.V., J.E., M.K.K.), Toronto, Ontario, Canada; Institute of Health Policy Management and Evaluation (A.Y.X.Y., P.C.A., M.V.V., M.K.K.), University of Toronto, Ontario, Canada; Department of Medicine (Neurology) (M.V.V.), University of Toronto, Unity Health Toronto, Ontario, Canada; Department of Clinical Neurosciences (E.S.), Community Health Sciences, and Hotchkiss Brain Institute, University of Calgary, Alberta, Canada; Department of Medicine (R.A.J.), Hamilton Health Sciences Centre, McMaster University, Ontario, Canada; University of Ottawa Heart Institute (J.E.), Ontario, Canada; School of Epidemiology and Public Heath (J.E.), University of Ottawa, Ontario, Canada; Department of Epidemiology and Biostatistics M.J.R., College of Human Medicine, Michigan State University, East Lansing; and Department of Medicine (General Internal Medicine) (M.K.K.), University of Toronto-University Health Network, Ontario, Canada.

Published: January 2023

Background And Objectives: Sex differences in stroke care and outcomes have been previously reported, but it is not known whether these associations vary across the age continuum. We evaluated whether the magnitude of female-male differences in care and outcomes varied with age.

Methods: In a population-based cohort study, we identified patients hospitalized with ischemic stroke between 2012 and 2019 and followed through 2020 in Ontario, Canada, using administrative data. We evaluated sex differences in receiving intensive care unit services, mechanical ventilation, gastrostomy tube insertion, comprehensive stroke center care, stroke unit care, thrombolysis, and endovascular thrombectomy using logistic regression and reported odds ratios (ORs) and 95% CIs. We used Cox proportional hazard models and reported the hazard ratios (HRs) and 95% CI of death within 90 or 365 days. Models were adjusted for covariates and included an interaction between age and sex. We used restricted cubic splines to model the relationship between age and care and outcomes. Where the -value for interaction was statistically significant ( < 0.05), we reported age-specific OR or HR.

Results: Among 67,442 patients with ischemic stroke, 45.9% were female and the median age was 74 years (64-83). Care was similar between both sexes, except female patients had higher odds of receiving endovascular thrombectomy (OR 1.35, 95% CI [1.19-1.54] comparing female with male), and these associations were not modified by age. There was no overall sex difference in hazard of death (HR 95% CI 0.99 [0.95-1.04] for death within 90 days; 0.99 [0.96-1.03] for death within 365 days), but these associations were modified by age with the hazard of death being higher in female than male patients between the ages of 50-70 years (most extreme difference around age 57, HR 95% CI 1.25 [1.10-1.40] at 90 days, p-interaction 0.002; 1.15 [1.10-1.20] at 365 days, p-interaction 0.002).

Discussion: The hazard of death after stroke was higher in female than male patients aged 50-70 years. Examining overall sex differences in outcomes without accounting for the effect modification by age may miss important findings in specific age groups.

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000201372DOI Listing

Publication Analysis

Top Keywords

sex differences
16
care outcomes
16
ischemic stroke
12
365 days
12
female male
12
hazard death
12
age
10
care
8
age continuum
8
endovascular thrombectomy
8

Similar Publications

Background: Radioactive iodine (RAI) is a common treatment for various thyroid diseases. Previous studies have suggested susceptibility of parathyroid glands to the mutagenic effect of RAI and the development of primary hyperparathyroidism (PHPT). We tested the possible link between prior RAI treatment, disease presentation, and treatment outcomes.

View Article and Find Full Text PDF

Desmopressin (DDAVP) can be used to prevent or stop bleeding. However, large inter-individual variability is observed in DDAVP response and determinants are largely unknown. In this systematic review and meta-analysis we aim to identify the response to DDAVP, and the factors that determine DDAVP response in patients.

View Article and Find Full Text PDF

Purpose: Fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) protein overexpression is an emerging biomarker in gastric cancer and gastroesophageal junction cancer (GC). We assessed FGFR2b protein overexpression prevalence in nearly 3,800 tumor samples as part of the prescreening process for a global phase III study in patients with newly diagnosed advanced or metastatic GC.

Methods: As of June 28, 2024, 3,782 tumor samples from prescreened patients from 37 countries for the phase III FORTITUDE-101 trial (ClinicalTrials.

View Article and Find Full Text PDF

Background: Cervical cancer screening program in Uganda is opportunistic and focuses mainly on women aged 25-49 years. Female sex workers (FSWs) are at increased risk of developing invasive cervical cancer. There is limited data regarding the uptake and acceptability of cervical cancer screening among FSWs in Uganda.

View Article and Find Full Text PDF

The accessory navicular (AN) is an accessory bone located on the posteromedial aspect of the navicular tuberosity that can cause pain following overuse or trauma, particularly during childhood. However, the detailed epidemiological characteristics of AN in children have not been well studied. This study aimed to clarify the prevalence of AN and painful AN among Japanese children by examining the characteristics according to sex and age.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!